Back to Agenda
Session 4: MedDRA for Signal Detection and Data Analysis
Session Chair(s)
Mick Foy
Director of Delivery
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Patrick Revelle
MSSO Director
MedDRA MSSO, United States
This session will provide important insight into the use of MedDRA for signal detection and data analysis including an overview of the key aspects described in the ICH-endorsed “MedDRA Data Retrieval and Presentation: Points to Consider” document. Various approaches to data analysis such as the use of the MedDRA hierarchy and secondary System Organ Class (SOC) analyses will be presented. Standardised MedDRA Queries and their application in case identification and signal detection will be discussed. The presentations will provide both a regulatory and industry perspective on this topic.
Speaker(s)
Use of MedDRA in signal detection and evaluation
Phil Tregunno
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Deputy Director - Patient Safety Monitoring
Safety signals, data retrieval and analysis – industry perspective
Christina Winter, MD, FFPM
Glaxosmithkline, United Kingdom
Safety Evaluation and Risk Management
Have an account?